Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures
Open accessPublished version of a preprint
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deep sequencing of B cell receptor (BCR) heavy chains from a cohort of 31 COVID-19 patients from the UK reveals a stereotypical naive immune response to SARS-CoV-2 which is consistent across patients. Clonal expansion of the B cell population is also observed and may be the result of memory bystander effects. There was a strong convergent sequence signature across patients, and we identified 1,254 clonotypes convergent between at least four of the COVID-19 patients, but not present in healthy controls or individuals following seasonal influenza vaccination. A subset of the convergent clonotypes were homologous to known SARS and SARS-CoV-2 spike protein neutralizing antibodies. Convergence was also demonstrated across wide geographies by comparison of data sets between patients from UK, USA, and China, further validating the disease association and consistency of the stereotypical immune response even at the sequence level. These convergent clonotypes provide a resource to identify potential therapeutic and prophylactic antibodies and demonstrate the potential of BCR profiling as a tool to help understand patient responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cd-hit: Accelerated for clustering the next-generation sequencing data
Fu, L., Niu, B., Zhu, Z., Wu, S., & Li, W. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts565 · Cited by 11,175
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · doi:10.1101/2020.04.07.023903 · Cited by 1,752
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science · doi:10.1126/science.abc5902 · Cited by 1,140
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Ng, K. W., Faulkner, N., Cornish, G. H., Rosa, A., Harvey, R., Hussain, S., Ulferts, R., Earl, C., Wrobel, A. G., Benton, D. J., et al. (2020) · Science · doi:10.1126/science.abe1107 · Cited by 886 · cited 1×
“Such a secondary response to SARS-CoV-2 has been previously observed (47) and may be due to recall of B cells activated in response to previously circulating human coronaviruses, as recently highlighted (48, 49).”
BackgroundCommonality despite exceptional diversity in the baseline human antibody repertoire
Briney, B., Inderbitzin, A., Joyce, C., & Burton, D. R. (2019) · Nature · doi:10.1038/s41586-019-0879-y · Cited by 544
CoV-AbDab: the coronavirus antibody database
Raybould, M. I. J., Kovaltsuk, A., Marks, C., & Deane, C. M. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa739 · Cited by 383
Self-citation
Research works printed but not linked: 42
- Lu, 2020, Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle, J Med Virol, 92, 10.1002/jmv.25678 · DOI · Paper page
- Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
- Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 10.1056/NEJMoa1910993 · DOI · Paper page
- Gogtay, 2018, Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study, Clin Infect Dis, 66, 10.1093/cid/cix791 · DOI
- Johnson, 1997, Development of a Humanized Monoclonal Antibody (MEDI-493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus, J Infect Dis, 176, 10.1086/514115 · DOI · Paper page
- Wang, 2014, Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins, Biochem Biophys Res Commun, 451, 10.1016/j.bbrc.2014.07.090 · DOI · Paper page
- Tetro, 2020, Is COVID-19 receiving ADE from other coronaviruses, Microbes Infect, 22, 10.1016/j.micinf.2020.02.006 · DOI · Paper page
- Sharma, 2020, It is too soon to attribute ADE to COVID-19, Microbes Infect, 22, 158, 10.1016/j.micinf.2020.03.005 · doi:10.1016/j.micinf.2020.03.005
- Wang, 2016, Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates, ACS Infect Dis, 2, 10.1021/acsinfecdis.6b00006 · DOI · Paper page
- Andreano, 2020, Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients, bioRxiv, 10.1101/2020.05.05.078154 · DOI
- Nielsen, 2020, Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2, Cell Host Microbe, 28, 516, 10.1016/j.chom.2020.09.002 · DOI · Paper page
- De Mattos-Arruda, 2019, The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer, Cell Rep, 27, 2690, 10.1016/j.celrep.2019.04.098 · DOI
- van Dongen, 2003, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia, 17, 10.1038/sj.leu.2403202 · DOI · Paper page
- Vander Heiden, 2014, pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires, Bioinformatics, 30, 10.1093/bioinformatics/btu138 · DOI · Paper page
- Gupta, 2015, Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data, Bioinformatics, 31, 10.1093/bioinformatics/btv359 · DOI · Paper page
- Edgar, 2010, Search and clustering orders of magnitude faster than BLAST, Bioinformatics, 26, 10.1093/bioinformatics/btq461 · DOI · Paper page
- Ye, 2013, IgBLAST: an immunoglobulin variable domain sequence analysis tool, Nucleic Acids Res, 41, 10.1093/nar/gkt382 · DOI · Paper page
- Ghraichy, 2020, Maturation of the Human B-Cell Receptor Repertoire with Age, Front Immunol, 11, 1734, 10.2139/ssrn.3518535 · doi:10.2139/ssrn.3518535
- Tipton, 2015, Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus, Nat Immunol, 16, 10.1038/ni.3175 · DOI · Paper page
- Gupta, 2017, Hierarchical Clustering Can Identify B Cell Clones with High Confidence in Ig Repertoire Sequencing Data, J Immunol, 198, 10.4049/jimmunol.1601850 · DOI · Paper page
- Galson, 2015, BCR repertoire sequencing: different patterns of B cell activation after two Meningococcal vaccines, Immunol Cell Biol, 93, 10.1038/icb.2015.57 · DOI · Paper page
- Gupta, 2015, Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data, Bioinformatics, 1, 10.1093/bioinformatics/btv359 · DOI · Paper page
- Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 10.1038/s41586-020-2012-7 · DOI · Paper page
- Bolotin, 2015, MiXCR: software for comprehensive adaptive immunity profiling, Nat Methods, 12, 10.1038/nmeth.3364 · DOI · Paper page
- Wickham, 2009, ggplot2: Elegant Graphics for Data Analysis, 10.1007/978-0-387-98141-3 · DOI · Paper page
- Tavakolpour, 2020, Lymphopenia during the COVID-19 infection: What it shows and what can be learned, Immunol Lett, 225, 10.1016/j.imlet.2020.06.013 · DOI · Paper page
- Pascual, 1991, Nucleotide sequence analysis of the V regions of two IgM cold agglutinins: Evidence that the V(H)4-21 gene segment is responsible for the major cross-reactive idiotype, J Immunol, 146, 10.4049/jimmunol.146.12.4385 · DOI · Paper page
- Horns, 2016, Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching, Elife, 5, 1, 10.7554/eLife.16578 · DOI
- Parameswaran, 2013, Convergent Antibody Signatures in Human Dengue, Cell Host Microbe, 13, 691, 10.1016/j.chom.2013.05.008 · DOI · Paper page
- Zost, 2020, Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein, Nat Med, 26, 10.1038/s41591-020-0998-x · DOI · Paper page
- Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Sci (80- ), 369, 10.1126/science.abc7520 · DOI · Paper page
- Seydoux, 2020, Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual, bioRxiv, 10.1101/2020.05.12.091298 · DOI · Paper page
- Li, 2020, IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity, bioRxiv, 10.1101/2020.05.15.096719 · DOI
- Wec, 2020, Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine, Proc Natl Acad Sci USA, 117, 10.1073/pnas.1921388117 · DOI · Paper page
- Tian, 2008, Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones, J Immunol, 180, 10.4049/jimmunol.180.5.3279 · DOI
- Godoy-Lozano, 2016, Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response, Genome Med, 8, 23, 10.1186/s13073-016-0276-1 · DOI
- Kalinke, 2000, Virus neutralization by germ-line vs. hypermutated antibodies, Proc Natl Acad Sci USA, 97, 10.1073/pnas.97.18.10126 · doi:10.1073/pnas.97.18.10126
- Wec, 2020, Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein, bioRxiv, 10.1101/2020.05.15.096511 · DOI
- Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci, 117, 202004168, 10.1073/pnas.2004168117 · DOI · Paper page
- Galson, 2020, Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures, bioRxiv, 10.1101/2020.05.20.106294 · DOI
- Corrie, 2018, iReceptor: A platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories, Immunol Rev, 284, 24, 10.1111/imr.12666 · DOI · Paper page
Cited by
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244126 · Cited by 374
T cell response to SARS-CoV-2 infection in humans: A systematic review
Shrotri, M., van Schalkwyk, M. C. I., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245532 · Cited by 350
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.012 · Cited by 328
Self-citationNguyen-Contant, P., Embong, A. K., Kanagaiah, P., Chaves, F. A., Yang, H., Branche, A. R., Topham, D. J., & Sangster, M. Y. (2020) · mBio · doi:10.1128/mbio.01991-20 · Cited by 204
Metadata
- Authors
- Galson, J. D., Schaetzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J., James, L. K., Thomas, G., Lee, W.-Y. J., Betley, J., Cavlan, O., Leech, A., Deane, C. M., Seoane, J., Caldas, C., Pennington, D. J., Pfeffer, P., & Osbourn, J.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-15
- Volume
- 11
- Pages
- 605170-605170
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3111287171
- Cited by
- 139
- References
- 12
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures. https://app.cochat.ai/papers/10.3389/fimmu.2020.605170
- The paper
- Galson, J. D., Schaetzle, S., Bashford-Rogers, R. J. M., Raybould, M. I. J., Kovaltsuk, A., Kilpatrick, G. J., Minter, R., Finch, D. K., Dias, J., James, L. K., Thomas, G., Lee, W.-Y. J., Betley, J., Cavlan, O., Leech, A., Deane, C. M., Seoane, J., Caldas, C., Pennington, D. J., . . . Osbourn, J. (2020). Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.605170
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.